期刊文献+
共找到58篇文章
< 1 2 3 >
每页显示 20 50 100
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma 被引量:17
1
作者 Shan-Long Ding Zi-Wei Yang +3 位作者 Jie Wang Xiao-Lei Zhang Xiang-Mei Chen Feng-Min Lu 《World Journal of Gastroenterology》 SCIE CAS 2015年第20期6317-6328,共12页
AIM: To comprehensively understand the underlying molecular events accounting for aberrant Wnt signaling activation in hepatocellular carcinoma(HCC).METHODS: This study was retrospective. The HCC tissue specimens used... AIM: To comprehensively understand the underlying molecular events accounting for aberrant Wnt signaling activation in hepatocellular carcinoma(HCC).METHODS: This study was retrospective. The HCC tissue specimens used in this research were obtained from patients who underwent liver surgery. The Catalogue of Somatic Mutations in Cancer(COSMIC) database was searched for the mutation statuses of CTNNB1, TP53, and protein degradation regulator genes of CTNNB1. Dual-luciferase reporter assay was performed with TOP/FOP reporters to detect whether TP53 gain-of-function(GOF) mutations could enhance the transcriptional activity of Wnt signaling. Methylation sensitive restriction enzyme-quantitative PCR was used to explore the methylation status of Cp G islands located in the promoters of APC, SFRP1, and SFRP5 in HCCs with different risk factors. Finally, nestedreverse transcription PCR was performed to examine the integration of HBx in front of LINE1 element and the existence of HBx-LINE1 chimeric transcript in Hepatitis B virus-related HCC. All results in this article were analyzed with the software SPSS version 19.0 for Windows, and different groups were compared by χ2 test as appropriate.RESULTS: Based on the data from COSMIC database, compared with other solid tumors, mutation frequency of CTNNB1 was significantly higher in HCC(P < 0.01). The rate of CTNNB1 mutation was significantly less frequent in Hepatitis B virus-related HCC than in other etiologies(P < 0.01). Dual-luciferase reporter system and TOP/FOP reporter assays confirmed that TP53 GOF mutants were able to enhance the transcriptional ability of Wnt signaling. An exclusive relationship between the status of TP53 and CTNNB1 mutations was observed. However, according to the COSMIC database, TP53 GOF mutation is rare in HCC, which indicates that TP53 GOF mutation is not a reason for the aberrant activation of Wnt signaling in HCC. APC and AXIN1 were mutated in HCC. By using methylation sensitive restriction enzyme-quantitative PCR, hypermethylation of APC was 展开更多
关键词 β-catenin ctnnb1 HEPATITIS B virus HEPATOCELLULAR carcinoma TP53 WNT signaling
下载PDF
益气活血方和补肾生髓方对局灶性脑缺血再灌注大鼠Ctnnb1和Krt1基因及其蛋白表达的影响 被引量:11
2
作者 徐伟 胡建鹏 +5 位作者 王键 吴生兵 王丽娜 何玲 菅威 谭辉 《北京中医药大学学报》 CAS CSCD 北大核心 2014年第2期112-115,I0004,共5页
目的探讨益气活血方和补肾生髓方对脑缺血再灌注大鼠Ctnnb1和Krt1基因及其蛋白表达的影响。方法制作局灶性脑缺血再灌注大鼠模型,随机分为假手术组、模型组、益气活血方组和补肾生髓方组,脑缺血2 h后再灌注。采用PCR法检测缺血侧额顶叶... 目的探讨益气活血方和补肾生髓方对脑缺血再灌注大鼠Ctnnb1和Krt1基因及其蛋白表达的影响。方法制作局灶性脑缺血再灌注大鼠模型,随机分为假手术组、模型组、益气活血方组和补肾生髓方组,脑缺血2 h后再灌注。采用PCR法检测缺血侧额顶叶皮质Ctnnb1和Krt1基因表达,用免疫组化Envision两步法检测缺血侧额顶叶皮质区和海马CA1区蛋白表达。结果与假手术组比较,模型组Ctnnb1和Krt1基因表达显著上调(P<0.05);与模型组比较,益气活血方组Ctnnb1和Krt1基因表达显著下调(P<0.05),补肾生髓方组Ctnnb1基因表达显著下调(P<0.05),益气活血方组Ctnnb1基因下调与补肾生髓方组有显著差别(P<0.05)。在额顶叶皮质区和海马CA1区,与假手术组比较,模型组Ctnnb1和Krt1蛋白表达显著升高(P<0.05);与模型组比较,益气活血方组与补肾生髓方组Ctnnb1和Krt1蛋白表达均显著降低(P<0.05);益气活血方组Ctnnb1蛋白表达显著低于补肾生髓方组(P<0.05)。结论两种中药复方能通过降低皮质或海马Ctnnb1和Krt1基因及其蛋白表达,调节Notch信号通路,促进局灶性脑缺血再灌注损伤脑组织修复。 展开更多
关键词 益气活血方 补肾生髓方 脑缺血再灌注 海马CA1 ctnnb1 Krt1 大鼠
原文传递
Association of Controlled Ovarian Hyperstimulation Treatment with Down-regulation of Key Regulators Involved in Embryonic Implantation in Mice 被引量:9
3
作者 熊敏 章汉旺 +3 位作者 靳镭 艾继辉 黄志勇 朱桂金 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2011年第4期535-542,共8页
The debate exists whether or not gonadotropin-releasing hormone(GnRH) analogs used in controlled ovarian hyperstimulation(COH) impair endometrial receptivity.Homeobox A11(Hoxa11),Meis homeobox 1(Meis1),cadheri... The debate exists whether or not gonadotropin-releasing hormone(GnRH) analogs used in controlled ovarian hyperstimulation(COH) impair endometrial receptivity.Homeobox A11(Hoxa11),Meis homeobox 1(Meis1),cadherin 1(Cdh1),and catenin beta 1(Ctnnb1) are well known to be involved in successful implantation.In this study,the endometrial expression of Hoxa11,Meis1,Cdh1,and Ctnnb1 during the peri-implantation period was investigated in an in vitro fertilization(IVF) mouse model by real-time RT-PCR and Western blot to evaluate the relationship between Hoxa11,Meis1,Cdh1,and Ctnnb1 expression and the impact of the COH on endometrial receptivity.The mimic COH protocols included GnRH agonist plus human menopausal gonadotropin(HMG)(GnRH agonist group),GnRH antagonist plus HMG(GnRH antagonist group),and HMG alone(HMG group).The expression levels of Hoxa11,Meis1,Cdh1,and Ctnnb1 mRNA and protein were decreased in all of the COH groups.The expression levels of Hoxa11 and Ctnnb1 were the lowest in the GnRH agonist group,and those of Meis1 and Cdh1 were lower in the GnRH analog groups than the HMG group.There were positive correlations between the expression of Hoxa11 and Ctnnb1,as well as the expression of Meis1 and Cdh1 among all the groups.In conclusion,the COH protocols,particularly with GnRH analogs,suppressed Hoxa11,Meis1,Ctnnb1 and Cdh1 expression,in mouse endometrium during the peri-implantation period.Our data reveal a novel molecular mechanism by which the COH protocols might impair endometrial receptivity. 展开更多
关键词 assisted reproductive technology GnRH analog HOXA11 Meis1 CDH1 ctnnb1 E-CADHERIN endometrial receptivity
下载PDF
WNT/β-catenin signaling in hepatocellular carcinoma:The aberrant activation,pathogenic roles,and therapeutic opportunities 被引量:5
4
作者 Anna Gajos-Michniewicz Malgorzata Czyz 《Genes & Diseases》 SCIE CSCD 2024年第2期727-746,共20页
Hepatocellular carcinoma(HCC)is a liver cancer,highly heterogeneous both at the histopathological and molecular levels.It arises from hepatocytes as the result of the accumulation of numerous genomic alterations in va... Hepatocellular carcinoma(HCC)is a liver cancer,highly heterogeneous both at the histopathological and molecular levels.It arises from hepatocytes as the result of the accumulation of numerous genomic alterations in various signaling pathways,including canonical WNT/β-catenin,AKT/mTOR,MAPK pathways as well as signaling associated with telomere maintenance,p53/cell cycle regulation,epigenetic modifiers,and oxidative stress.The role of WNT/β-catenin signaling in liver homeostasis and regeneration is well established,whereas in development and progression of HCC is extensively studied.Herein,we review recent advances in our understanding of how WNT/β-catenin signaling facilitates the HCC development,acquisition of stemness features,metastasis,and resistance to treatment.We outline genetic and epigenetic alterations that lead to activated WNT/β-catenin signaling in HCC.We discuss the pivotal roles of CTNNB1 mutations,aberrantly expressed non-coding RNAs and complexity of crosstalk between WNT/β-catenin signaling and other signaling pathways as challenging or advantageous aspects of therapy development and molecular stratification of HCC patients for treatment. 展开更多
关键词 Cancer stem cells ctnnb1 mutations Liver cancer Non-coding RNA Tumor heterogeneity
原文传递
Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers 被引量:10
5
作者 Worrawit Wanitsuwan Samornmas Kanngurn +2 位作者 Teeranut Boonpipattanapong Rassamee Sangthong Surasak Sangkhathat 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第39期6052-6059,共8页
AIM: To examine the expression of beta-catenin in colorectal cancer and look for association with other dinico-pathological parameters. METHODS;: Tumor samples from 163 cases of colorectal cancer (CRC) who had und... AIM: To examine the expression of beta-catenin in colorectal cancer and look for association with other dinico-pathological parameters. METHODS;: Tumor samples from 163 cases of colorectal cancer (CRC) who had undergone primary colectomy between May, 1998 and November, 2002 with complete follow-up data for either 5 years or until death were recruited for a beta-catenin immunohistochemical study. The percentage of immunoreacted tumor cells was defined as overall staining density (OSD) and percentage of cells having nuclear localization was counted as nuclear staining density (NSD). Univariate exploration used log-rank test and multivariate survival analysis used Cox's hazard regression model. RESULTS: Beta-catenin immunoreactivity was detected in 161 samples (98.8%), of which 131 cases had nuclear staining. High OSD (≥ 75%), detected in 123 cases (75.5%), was significantly associated with earlier clinical staging (P 〈 0.01), lower nodal status (P = 0.02), non-metastatic status (P 〈 0.01) and better differentiation (P = 0.02). Multivariate analysis found that high OSD was independently associated with better survival [Cox's hazard ratio 0.51, 95% confidence interval (CI) 0.31-0.83]. Although high NSD (≥ 75%) was correlated with high pre-operative serum CEA (P = 0.03), well differentiation (P 〈 0.01), and increased staining intensity(P 〈 0.01), the parameter was not significantly associated with survival. CONCLI3SIOM: Unlike previous reports, the study did not find a predictive value of nuclear beta-catenin in CRC. Instead, the overall expression of beta-catenin in CRC showed an association with better differentiation and earlier staging. Moreover, the parameter also independently predicted superior survival. 展开更多
关键词 Colorectal carcinoma BETA-CATENIN ctnnb1 Wnt-signaling pathway PROGNOSIS
下载PDF
miR-124-3p调控激素性股骨头坏死患者骨髓间充质干细胞成骨分化作用的研究 被引量:1
6
作者 杨增强 郝飞虎 +2 位作者 原天祎 周治衡 崔泳 《生物骨科材料与临床研究》 CAS 2024年第1期7-13,共7页
目的探讨miRNAs和CTNNB1在激素性股骨头坏死患者中的表达水平,以及miR-124-3p对骨髓间充质干细胞成骨分化的影响。方法选择2020年9月至2022年5月就诊于新疆医科大学第五附属医院行髋关节置换术的患者30例,激素性股骨头坏死患者15例作为... 目的探讨miRNAs和CTNNB1在激素性股骨头坏死患者中的表达水平,以及miR-124-3p对骨髓间充质干细胞成骨分化的影响。方法选择2020年9月至2022年5月就诊于新疆医科大学第五附属医院行髋关节置换术的患者30例,激素性股骨头坏死患者15例作为实验组,股骨颈骨折患者15例作为对照组。术中扩髓时收集患者的骨髓组织,提取总mRNA,应用qRT-PCR检测各组miR-322-5p、miR-124-3p、miR-125a-3p及CTNNB1的表达量,用Western Blot检测CTNNB1蛋白的表达量。在骨髓间充质干细胞(BMSCs)中转染miR-124-3p的模拟物和抑制剂来检测其对BMSCs分化的影响作用,并验证miR-124-3p与CTNNB1的靶标关系。结果在实验组BMSCs中miR-125a-3p、CTNNB1表达量高于对照组(P<0.05);miR-124-3p的表达量低于对照组(P<0.001),miR-322-5p的表达量在两组中无明显差异。转染miR-124-3p+mimics组的miR-124-3p表达量高于其他组,CTNNB1表达量低于其他组(P<0.001),转染miR-124-3p inhibitor组的结果则相反。分化能力评估发现过表达miR-124-3p可以促进BMSCs成骨分化能力,抑制表达则结果相反。双荧光素酶报告系统结果显示,miR-124-3p与CTNNB1有靶向结合关系。结论miR-124-3p可以靶向CTNNB1,并且miR-124-3p可以调控骨髓间充质干细胞并促进其成骨分化。 展开更多
关键词 激素性股骨头坏死 骨髓间充质干细胞 miR-124-3p ctnnb1
下载PDF
Genotype phenotype classification of hepatocellular adenoma 被引量:7
7
作者 Paulette Bioulac-Sage Jean Frédéric Blanc +2 位作者 Sandra Rebouissou Charles Balabaud Jessica Zucman-Rossi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第19期2649-2654,共6页
Studies that compare tumor genotype with phenotype have provided the basis of a new histological/molecular classification of hepatocellular adenomas. Based on two molecular criteria (presence of a TCFI/HNF1α or β-c... Studies that compare tumor genotype with phenotype have provided the basis of a new histological/molecular classification of hepatocellular adenomas. Based on two molecular criteria (presence of a TCFI/HNF1α or β-catenin mutation), and an additional histological criterion (presence or absence of an inflammatory infiltrate), subgroups of hepatocellular adenoma can be defined and distinguished from focal nodular hyperplasia. Analysis of 96 hepatocellular adenomas performed by a French collaborative network showed that they can be divided into four broad subgroups: the first one is defined by the presence of mutations in TCF1 gene inactivating the hepatocyte nuclear factor 1 (HNF1α), the second by the presence of β-catenin activating mutations; the category without mutations of HNF1α or β-catenin is further divided into 2 subgroups depending on the presence or absence of inflammation. Therefore, the approach to the diagnosis of problematic benign hepatocytic nodules may be entering a new era directed by new molecular information. It is hoped that immunohistological tools will improve significantly diagnosis of liver biopsy in our ability to distinguish hepatocellular adenoma from focal nodular hyperplasia (FNH), and to delineate clinically meaningful entities within each group to define the best clinical management. The optimal care of patients with a liver nodule will benefit from the recent knowledge coming from molecular biology and the combined expertise of hepatologists, pathologists, radiologists, and surgeons. 展开更多
关键词 Hepatocellular adenoma HNF1α mutation β-catenin mutation Inflammatory adenoma Telangiectatic adenoma Maturity-onset diabetes of theyoung Hepatocyte nuclear factor 1 ctnnb1 Focal nodular hyperplasia
下载PDF
马乳源性生物活性肽生物学信息及其抗肺癌作用靶点探索
8
作者 古丽巴哈尔·卡吾力 马建宝 +2 位作者 卡丽比努尔·艾尔肯 徐志伟 高晓黎 《中国乳品工业》 CAS 北大核心 2024年第1期17-21,64,共6页
在前期研究基础上通过在线软件对已知氨基酸组成的马乳源性活性肽生物学信息和关键靶蛋白进行分析并进行分子对接,探索马乳源性活性肽抗肺癌作用靶点。结果表明马乳源的活性肽为不稳定、带正电荷的亲水性多肽,是没有跨膜区和信号肽,也... 在前期研究基础上通过在线软件对已知氨基酸组成的马乳源性活性肽生物学信息和关键靶蛋白进行分析并进行分子对接,探索马乳源性活性肽抗肺癌作用靶点。结果表明马乳源的活性肽为不稳定、带正电荷的亲水性多肽,是没有跨膜区和信号肽,也没有糖基化和磷酸化位点的细胞膜外多肽,二级结构主要以无规则卷曲为主,与肺癌相关的核心靶点即CTNNB1、FGFR2、FOXF1、KRAS、NKX2-1、TGFBR2具有很好的结合亲和力,为深入研究马乳源活性肽的生物学功能奠定了基础。 展开更多
关键词 抗氧化肽 生物学信息 分子对接 肺癌 NKX2-1 ctnnb1
下载PDF
宫颈癌组织CTNNB1和TP53表达特点及其临床意义研究 被引量:6
9
作者 李志强 王琳冬 闫学花 《临床和实验医学杂志》 2020年第10期1081-1085,共5页
目的研究宫颈癌组织钙黏蛋白相关蛋白(CTNNB1)、肿瘤抑制因子P53(TP53)表达特点及其临床意义。方法采用回顾性研究方法,选取2016年1月至2019年10月河北北方学院附属第二医院收治的124例宫颈癌患者(宫颈癌组)及124例宫颈良性疾病患者(良... 目的研究宫颈癌组织钙黏蛋白相关蛋白(CTNNB1)、肿瘤抑制因子P53(TP53)表达特点及其临床意义。方法采用回顾性研究方法,选取2016年1月至2019年10月河北北方学院附属第二医院收治的124例宫颈癌患者(宫颈癌组)及124例宫颈良性疾病患者(良性组),比较不同组织中CTNNB1 mRNA、TP53 mRNA的表达情况及CTNNB1 mRNA、TP53 mRNA不同表达者的临床病理特征,采用Spearman分析CTNNB1 mRNA、TP53 mRNA与临床病理特征的相关性,采用受试者操作特征曲线(ROC)及ROC下面积(AUC)分析CTNNB1 mRNA、TP53 mRNA预测复发的价值。结果宫颈良性病变组织、癌旁组织、宫颈癌组织CTNNB1 mRNA表达分别为0.18±0.05、0.56±0.14、3.89±1.23,依次升高,TP53 mRNA表达分别为0.67±0.22、0.15±0.04、0.09±0.02,依次降低,组间比较差异均具有统计学意义(P<0.05);CTNNB1 mRNA、TP53 mRNA高低表达者国际妇产科联盟(FIGO)分期、分化程度、淋巴结转移比较,差异均具有统计学意义(P<0.05);CTNNB1 mRNA与FIGO分期(r=0.596)、腹主动脉旁淋巴结转移(r=0.648)、盆腔淋巴结转移(r=0.727)呈正相关,与分化程度(r=-0.312)呈负相关(P<0.05);TP53 mRNA与FIGO分期(r=-0.732)、腹主动脉旁淋巴结转移(r=-0.841)、盆腔淋巴结转移(r=-0.675)呈负相关,与分化程度(r=0.516)呈正相关(P<0.05);复发患者CTNNB1 mRNA为5.93±1.81,高于未复发患者的3.12±1.01,TP53 mRNA为0.10±0.02,低于未复发患者的0.06±0.02,差异有统计学意义(P<0.05);CTNNB1 mRNA预测复发的AUC为0.715,TP53mRNA预测复发的AUC为0.773,CTNNB1 mRNA+TP53 mRNA预测复发的AUC为0.881,差异有统计学意义(P<0.05)。结论宫颈癌组织中CTNNB1呈高表达,TP53呈低表达,与组织分化程度、淋巴结转移、肿瘤分期显著相关,并能预测宫颈癌术后复发的风险。 展开更多
关键词 宫颈癌 ctnnb1 TP53 病理特征 术后复发
下载PDF
基于生物信息学及动物实验对芪黄固肾通络方治疗糖尿病肾病的研究 被引量:1
10
作者 李新宝 庞欣欣 +4 位作者 彭紫凝 商海涛 朱清 郑威 韩佳瑞 《世界中医药》 CAS 北大核心 2024年第5期615-622,共8页
目的:探讨芪黄固肾通络方治疗糖尿病肾病(DKD)的作用机制。方法:通过人类基因数据库(GeneCards)、治疗靶点数据库(TTD)、人类疾病相关基因和突变基因数据库(DisGeNET)、综合性药物数据库(DrugBank)等数据库查找芪黄固肾通络方的活性成... 目的:探讨芪黄固肾通络方治疗糖尿病肾病(DKD)的作用机制。方法:通过人类基因数据库(GeneCards)、治疗靶点数据库(TTD)、人类疾病相关基因和突变基因数据库(DisGeNET)、综合性药物数据库(DrugBank)等数据库查找芪黄固肾通络方的活性成分、作用靶点、DKD相关的靶点。将药物目标点与病变靶点进行映射,将所获得的交集目标点构造蛋白质-蛋白质相互作用(PPI)网络与活性组分-联合目标网络,并进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析。通过动物实验对网络药理学结果中芪黄固肾通络方治疗糖尿病肾病核心靶点中富集节点较多的前3靶点进行验证。选取C57BL/6J小鼠为研究对象,链脲佐菌素(STZ)连续2次腹腔注射制备动物模型,8周后测小鼠24 h尿蛋白定量,分为正常组、模型组、模型+芪黄固肾通络方组,干预8周后,测胰岛素、C肽、尿素氮、24 h尿蛋白定量,qPCR及蛋白质印迹法(Western Blotting)检测小鼠肾脏CTNNB1、JUN、NCOA1表达。结果:GO与KEGG富集分析显示芪黄固肾通络方治疗DKD的有效靶点主要涉及晚期糖基化终末产物-晚期糖基化终末产物受体(AGE-RAGE)信号通路、血脂和动脉粥样硬化、流体剪切应力与动脉粥样硬化、神经活性配体-受体交互作用等;动物实验表明,芪黄固肾通络方能够降低DKD小鼠肾组织中连环蛋白β1(CTNNB1)、JUN、核受体辅激活蛋白1(NCOA1)的信使核糖核酸(mRNA)及蛋白表达,改善肾脏损伤。结论:通过网络药理学和实验验证,发现芪黄固肾通络方可能通过降低CTNNB1、JUN、NCOA1蛋白的表达水平干预AGE-RAGE等通路治疗DKD。 展开更多
关键词 芪黄固肾通络方 糖尿病肾病 网络药理学 动物实验 晚期糖基化终末产物-晚期糖基化终末产物受体 连环蛋白β JUN 核受体辅激活蛋白1
下载PDF
β-catenin表达与基因突变在侵袭性纤维瘤病诊断中的作用
11
作者 张科平 许洁 +2 位作者 刘志华 林丹义 陈洁 《诊断病理学杂志》 2023年第2期155-157,161,共4页
目的探讨β-catenin表达与基因突变在侵袭性纤维瘤病诊断中的作用。方法采用免疫组化方法和一代测序的方法对28例侵袭性纤维瘤病和32例形态学相似的梭形细胞肿瘤患者的石蜡组织进行β-catenin蛋白表达分析和CTNNB1基因突变检测。结果96.... 目的探讨β-catenin表达与基因突变在侵袭性纤维瘤病诊断中的作用。方法采用免疫组化方法和一代测序的方法对28例侵袭性纤维瘤病和32例形态学相似的梭形细胞肿瘤患者的石蜡组织进行β-catenin蛋白表达分析和CTNNB1基因突变检测。结果96.43%(27/28)的侵袭性纤维瘤病样本和46.88%(15/32)的对照样本中检测到β-catenin阳性表达(P<0.01);89.29%(25/28)的侵袭性纤维瘤病样本和对照样本中检测到CTNNB1基因突变(P<0.01)。在侵袭性纤维瘤病样本中,CTNNB1基因突变主要发生在41密码子和45密码子,其中41密码子突变率为64.29%(18/28)、45密码子突变率为25%(7/28)。结论β-catenin蛋白在侵袭性纤维瘤病中阳性率明显高于其他梭形细胞肿瘤,CTNNB1突变在侵袭性纤维瘤病中很常见,联合β-catenin表达和基因突变检测可辅助诊断侵袭性纤维瘤病。 展开更多
关键词 Β-CATENIN ctnnb1 侵袭性纤维瘤病
下载PDF
CTNNB1在食管鳞癌中的表达及其与放疗疗效的关系 被引量:4
12
作者 王炳淑 梁荣珍 戢楠楠 《临床和实验医学杂志》 2020年第15期1599-1602,共4页
目的检测CTNNB1蛋白在食管鳞癌中的表达,探讨CTNNB1与放疗疗效之间的关系及其临床意义。方法回顾性选取2010年1月至2012年12月海南医学院第二附属医院收治的59例患者,均为不能接受手术的局部晚期患者,经穿刺或诊断性手术诊断为食管鳞癌... 目的检测CTNNB1蛋白在食管鳞癌中的表达,探讨CTNNB1与放疗疗效之间的关系及其临床意义。方法回顾性选取2010年1月至2012年12月海南医学院第二附属医院收治的59例患者,均为不能接受手术的局部晚期患者,经穿刺或诊断性手术诊断为食管鳞癌,接受根治性放疗。采用免疫组化二步法检测上述患者食管癌组织中CTNNB1的表达。应用χ~2检验分析CTNNB1表达情况与患者放疗疗效及不同临床病理特征间的关系。结果 59例入组患者均完成放疗,其中放疗有效48例,无效11例,有效率为81.36%。在食管鳞癌组织中,CTNNB1蛋白主要表达在胞质及胞核中。CTNNB1蛋白总体表达水平与患者的性别、年龄、临床疗效、肿瘤病变长度、病理分级以及是否出现淋巴转移无明显相关性。CTNNB1蛋白核表达水平与患者的临床疗效呈负相关关系,与性别、年龄、肿瘤病变长度、病理分级以及是否出现淋巴转移无明显相关性。结论 CTNNB1蛋白在食管鳞癌中的表达与患者放疗之后的临床疗效存在明显的负相关关系,原因可能与食管鳞癌细胞的放射抗性有关,CTNNB1可以作为预测食管鳞癌放疗疗效的指标之一。 展开更多
关键词 食管鳞癌 ctnnb1 放疗疗效
下载PDF
加减养心通脉方干预对冠心病血瘀证亚型患者CTNNB1基因表达的影响及疗效观察 被引量:4
13
作者 向忠军 王建国 +5 位作者 简维雄 吴航宇 张月娟 黄海波 陈伶利 李杰 《湖南中医药大学学报》 CAS 2019年第9期1143-1147,共5页
目的探讨加减养心通脉方对冠心病血瘀证亚型CTNNB1基因表达及临床疗效观察。方法选择符合冠心病血瘀证诊断标准患者23例,按胸痹血瘀证亚型诊断标准分成冠心病气虚血瘀证组7例、气滞血瘀证组8例和痰浊血瘀证组8例,进行为期1个月的加减养... 目的探讨加减养心通脉方对冠心病血瘀证亚型CTNNB1基因表达及临床疗效观察。方法选择符合冠心病血瘀证诊断标准患者23例,按胸痹血瘀证亚型诊断标准分成冠心病气虚血瘀证组7例、气滞血瘀证组8例和痰浊血瘀证组8例,进行为期1个月的加减养心通脉方的治疗,采用实时荧光定量PCR仪检测服药前后CTNNB1基因表达的变化,观察服药前后血脂血糖临床疗效的变化。结果治疗后不同证型的患者相比治疗前CTNNB1基因表达改变不明显,差异无统计学意义(P>0.05);治疗后相比治疗前血糖值均有所下降,气虚血瘀组治疗前后血糖值改变差异有统计学意义(P<0.05);不同证型的患者中TC、TG在治疗后,比治疗前值均有所下降,3组治疗前后TC值改变差异有统计学意义(P<0.05);气滞血瘀证组、气虚血瘀证组TG改变有统计学意义(P<0.05);不同证型患者的HDL、LDLC值在治疗后相比治疗前均有所下降,但差异无统计学意义(P>0.05)。结论加减养心通脉方对冠心病血瘀证3个亚型(气虚、气滞、痰浊)CTNNB1基因表达无明显的调控作用,以方测证,说明CTNNB1基因的表达可能不是冠心病血瘀证的发病机制之一。但该方可以明显改善冠心病血瘀证亚型血糖及脂类异常,有较好的降脂和降糖作用。 展开更多
关键词 养心通脉方 冠心病 血瘀证亚型 ctnnb1 血脂 血糖
下载PDF
Identification of differentially expressed genes related to radioresistance of human esophageal cancer cells 被引量:5
14
作者 Hong-Zhen Li Xian-Shu Gao +3 位作者 Wei Xiong Jing Zhao Hai Zhang De-Min Zhou 《Chinese Journal of Cancer》 SCIE CAS CSCD 北大核心 2010年第10期882-888,共7页
Background and Objective: Radioresistant cells in esophageal cancer is one of the important reasons for the local failure of radiotherapy. In recent years, some researchers used gene chip technology to screen the diff... Background and Objective: Radioresistant cells in esophageal cancer is one of the important reasons for the local failure of radiotherapy. In recent years, some researchers used gene chip technology to screen the differentially expressed genes between parental and radioresistant human esophageal cancer cells. But there were some problems in these studies, for example comparing cells at only one time interval, and genetic background not matching. In this study, we selected 3 different pairs of parental and radioresistant human esophageal cancer cells, and compared the gene expression profiles by cDNA microarray at 3 time intervals to identify and analyze the differentially expressed genes between parental and radioresistant human esophageal cancer cells. Methods: We compared the gene expression profiles between parental cells (TE13, Seg-1, Kyse170) and radioresistant cells (TE13R, Seg-1R, Kyse170R) before, and at 8 h and 24 h after irradiation with a cDNA microarray consisting of 48 000 genes (Human Genome). We identified differentially expressed genes by Pathway and GO analyses, and verified the differentially expressed genes LEF1 and CTNNB1 by RT-PCR. Results: A total of 460, 451, and 397 differentially expressed genes were found before, and at 8 h and 24 h after irradiation. After Pathway and GO analyses, 14 differentially expressed genes, participating in cell growth, apoptosis, cell cycle regulation, gene repair and signal transmission, were selected to further research. LEF1 and CTNNB1 were verified by RT-PCR, and the results were consistent with those of cDNA microarray. Conclusions: The WNT signal pathway may be an important pathway participating in the formation of radioresistance of esophageal cancer cells. LEF1 and CTNNB1 may be the important genes causing the esophageal cancer cell radioresistance. 展开更多
关键词 差异表达基因 食管癌细胞 人类基因组 抗辐射 Wnt信号通路 CDNA微阵列 基因芯片技术 PCR检测
下载PDF
Regulation of CTNNB1 signaling in gastric cancer and stem cells 被引量:5
15
作者 Shihori Tanabe Kazuhiko Aoyagi +1 位作者 Hiroshi Yokozaki Hiroki Sasaki 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2016年第8期592-598,共7页
Recent research has shown that the alteration of combinations in gene expression contributes to cellular phenotypic changes. Previously, it has been demonstrated that the combination of cadherin 1 and cadherin 2 expre... Recent research has shown that the alteration of combinations in gene expression contributes to cellular phenotypic changes. Previously, it has been demonstrated that the combination of cadherin 1 and cadherin 2 expression can identify the diffuse-type and intestinal-type gastric cancers. Although the diffuse-type gastric cancer has been resistant to treatment, the precise mechanism and phenotypic involvement has not been revealed. It may be possible that stem cells transform into gastric cancer cells, possibly through the involvement of a molecule alteration and signaling mechanism. In this review article, we focus on the role of catenin beta 1 (CTNNB1 or &beta;-catenin) and describe the regulation of CTNNB1 signaling in gastric cancer and stem cells. 展开更多
关键词 ctnnb1 signaling &beta -CATENIN Epithelial-mesenchymal transition Gastric cancer Stem cell
下载PDF
睾丸微囊性间质肿瘤2例临床病理及分子特征分析 被引量:3
16
作者 刘宏 马杰 +5 位作者 王璇 夏秋媛 鲍炜 石群立 周晓军 沈勤 《临床与实验病理学杂志》 CAS CSCD 北大核心 2021年第1期49-53,共5页
目的观察2例睾丸微囊性间质肿瘤(microcystic stromal tumor,MCST)的临床病理学表现和分子改变。方法回顾性分析2例睾丸MCST的临床病理学及相关分子特征,运用免疫组化法及高通量基因测序技术检测MCST中的蛋白表达及基因状态。结果2例患... 目的观察2例睾丸微囊性间质肿瘤(microcystic stromal tumor,MCST)的临床病理学表现和分子改变。方法回顾性分析2例睾丸MCST的临床病理学及相关分子特征,运用免疫组化法及高通量基因测序技术检测MCST中的蛋白表达及基因状态。结果2例患者年龄分别为31岁和34岁,均偶然发现单侧睾丸肿大,无不适症状,肿瘤最大径分别为2.0 cm和1.7 cm。镜下见肿瘤呈结节状或分叶状膨胀性生长,瘤细胞呈微囊、网状、实性、漩涡状、条索状等多种形态,与玻变纤维不同比例混合。细胞形态较一致,胞质较丰富,核圆形~卵圆形,未见病理性核分裂及坏死。免疫表型:瘤细胞表达β-catenin(核染色)、CD10及CD99,不表达性索-间质肿瘤标志物(α-inhibin及Calretinin)。二代基因测序示2例均发生CTNNB1基因3号外显子突变,其中1例发生了APC基因突变。2例均行患侧睾丸根治术,术后分别随访14个月和29个月,均未见复发和转移。结论睾丸MCST极其罕见,除具有独特的微囊结构外,还具有更宽广的形态表现。发病机制与CTNNB1或APC基因突变有关,导致β-catenin核异常表达,归属性腺肿瘤中的独立病种之一。大多数肿瘤切除后治愈,生物学行为仍需深入探究。 展开更多
关键词 睾丸肿瘤 微囊性间质肿瘤 Β-CATENIN ctnnb1 APC
下载PDF
miR-885-5p通过靶向CTNNB1抑制胰腺癌细胞增殖、迁移和侵袭 被引量:2
17
作者 张丽云 范宇 李晓红 《现代肿瘤医学》 CAS 北大核心 2022年第17期3083-3088,共6页
目的:探讨miR-885-5p对胰腺癌细胞增殖、迁移和侵袭的影响,并阐明miR-885-5p和CTNNB1基因在胰腺癌细胞中的作用机制。方法:MTT、细胞划痕和Transwell实验测定各组细胞增殖、迁移与侵袭能力。双荧光素酶报告基因实验分析CTNNB1是否为miR-... 目的:探讨miR-885-5p对胰腺癌细胞增殖、迁移和侵袭的影响,并阐明miR-885-5p和CTNNB1基因在胰腺癌细胞中的作用机制。方法:MTT、细胞划痕和Transwell实验测定各组细胞增殖、迁移与侵袭能力。双荧光素酶报告基因实验分析CTNNB1是否为miR-885-5p的靶基因。使用胰腺癌TCGA数据进行预后分析,并进行miR-885-5p与CTNNB1表达的相关性分析。结果:下调miR-885-5p明显促进胰腺癌细胞增殖、迁移与侵袭,而过表达miR-885-5p则相反。miR-885-5p可靶向CTNNB13'UTR并抑制其转录后表达。在下调miR-885-5p的细胞中进行回复性实验,结果表明,miR-885-5p对胰腺癌细胞增殖、迁移与侵袭的抑制作用部分依赖于CTNNB1。TCGA数据库结果显示,miR-885-5p高表达的胰腺癌患者有较好的预后,且与CTNNB1表达呈负相关。结论:miR-885-5p通过靶向CTNNB1抑制胰腺癌细胞增殖、迁移与侵袭,miR-885-5p有望成为胰腺癌治疗的新靶点。 展开更多
关键词 miR-885-5p 胰腺癌 ctnnb1 增殖 迁移 侵袭
下载PDF
miR-330-3p在颞下颌关节骨关节炎软骨退变中的作用机制研究 被引量:2
18
作者 王楚瑶 邹璐芗 +1 位作者 陆川 何冬梅 《中国口腔颌面外科杂志》 CAS 2022年第4期320-327,共8页
目的:探讨miR-330-3p在颞下颌关节骨关节炎(temporomandibular joint osteoarthritis,TMJOA)软骨退变中的作用机制。方法:对SW1353软骨细胞系进行炎症及加压刺激,建立大鼠单侧前牙反(牙合)(unilateral anterior crossbite,UAC)TMJOA模型... 目的:探讨miR-330-3p在颞下颌关节骨关节炎(temporomandibular joint osteoarthritis,TMJOA)软骨退变中的作用机制。方法:对SW1353软骨细胞系进行炎症及加压刺激,建立大鼠单侧前牙反(牙合)(unilateral anterior crossbite,UAC)TMJOA模型,通过RT-qPCR检测体外及体内软骨OA情况下miR-330-3p的表达变化。miR-330-3p过表达或抑制后,利用EDU荧光染色以及蛋白免疫印迹(WB)检测SW1353软骨细胞的增殖及合成分解代谢变化。生物信息学分析预测并筛选miR-330-3p的下游靶点,并在炎症及加压刺激下通过RT-qPCR和WB明确miR-330-3p对其调控作用。在miR-330-3p大鼠UAC TMJOA模型的关节腔内注射后,采用免疫组织化学方法检测靶分子的表达及软骨代谢的变化,明确miR-330-3p对TMJOA的治疗作用。采用SPSS 22.0软件包对数据进行统计学分析。结果:在体外炎症和加压刺激下,以及大鼠UAC的TMJOA模型中,miR-330-3p在软骨中的表达均下降。抑制miR-330-3p可导致软骨细胞增殖能力下降,SOX9合成降低,MMP13表达增加,而过表达的结果则相反。生物信息学分析发现CTNNB1为可能的下游靶点之一,其在体外炎症和加压刺激后表达升高。过表达CTNNB1后,软骨细胞SOX9蛋白表达下降,MMP13蛋白表达升高,抑制CTNNB1的结果则相反。miR-330-3p与CTNNB1在mRNA及蛋白表达水平上存在负相关关系。大鼠UAC TMJOA模型关节腔内注射miR-330-3p模拟物后,CTNNB1的表达减少,软骨退变减轻。结论:miR-330-3p通过抑制CTNNB1的表达,减轻TMJOA的软骨退变。 展开更多
关键词 颞下颌骨关节炎 软骨退变 miR-330-3p ctnnb1
下载PDF
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation 被引量:3
19
作者 Jian Sun Tongzhu Jin +15 位作者 Zhihui Niu Jiayu Guo Yingying Guo Ruoxuan Yang Qianqian Wang Huiying Gao Yuhan Zhang Tianyu Li Wenxin He Zhixin Li Wenchao Ma Wei Su Liangliang Li Xingxing Fan Hongli Shan Haihai Liang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第9期3602-3617,共16页
Idiopathic pulmonary fibrosis(IPF)is a progressive disease with unknown etiology and limited therapeutic options.Activation of fibroblasts is a prominent feature of pulmonary fibrosis.Here we report that lncRNA DACH1(... Idiopathic pulmonary fibrosis(IPF)is a progressive disease with unknown etiology and limited therapeutic options.Activation of fibroblasts is a prominent feature of pulmonary fibrosis.Here we report that lncRNA DACH1(dachshund homolog 1)is downregulated in the lungs of IPF patients and in an experimental mouse model of lung fibrosis.LncDACH1 knockout mice develop spontaneous pulmonary fibrosis,whereas overexpression of LncDACH1 attenuated TGF-β1-induced aberrant activation,collagen deposition and differentiation of mouse lung fibroblasts.Similarly,forced expression of LncDACH1 not only prevented bleomycin(BLM)-induced lung fibrosis,but also reversed established lung fibrosis in a BLM model.Mechanistically,LncDACH1 binding to the serine/arginine-rich splicing factor 1(SRSF1)protein decreases its activity and inhibits the accumulation of Ctnnb1.Enhanced expression of SRSF1 blocked the anti-fibrotic effect of LncDACH1 in lung fibroblasts.Furthermore,loss of LncDACH1 promoted proliferation,differentiation,and extracellular matrix(ECM)deposition in mouse lung fibroblasts,whereas such effects were abolished by silencing of Ctnnb1.In addition,a conserved fragment of LncDACH1 alleviated hyperproliferation,ECM deposition and differentiation of MRC-5 cells driven by TGF-β1.Collectively,LncDACH1 inhibits lung fibrosis by interacting with SRSF1 to suppress CTNNB1 accumulation,suggesting that LncDACH1 might be a potential therapeutic target for pulmonary fibrosis. 展开更多
关键词 Idiopathic pulmonary fibrosis LncRNA DACH1 SRSF1 ctnnb1 FIBROBLAST MYOFIBROBLAST Extracellular matrix Proliferation
原文传递
卵巢癌患者CTNNB1、miR-34表达与临床病理特征及预后的关系 被引量:4
20
作者 张静 张红 +1 位作者 陈正莲 熊亮 《中国妇幼保健》 CAS 2019年第18期4325-4328,共4页
目的检测卵巢癌患者CTNNB1及miR-34的表达情况,探讨二者与临床病理特征及预后的关系。方法收集2013年7月-2015年2月在该院实施手术治疗的58例卵巢癌患者的组织标本为卵巢癌组,同期选取50例良性子宫肌瘤切除患者的卵巢无病变区域组织作... 目的检测卵巢癌患者CTNNB1及miR-34的表达情况,探讨二者与临床病理特征及预后的关系。方法收集2013年7月-2015年2月在该院实施手术治疗的58例卵巢癌患者的组织标本为卵巢癌组,同期选取50例良性子宫肌瘤切除患者的卵巢无病变区域组织作为对照组,分别采用免疫组化法检测CTNNB1蛋白表达情况,实时荧光定量PCR法对miR-34表达情况定量分析,探讨卵巢癌CTNNB1、miR-34表达情况与临床病理特征及其预后的关系。结果卵巢癌组中CTNNB1表达量远高于对照组(P<0. 05);miR-34表达量显著低于对照组(P<0. 05);卵巢癌组CTNNB1、miR-34表达量与FIGO分期、腹水量、卵巢癌组织、组织分化程度、淋巴结转移密切相关(P<0. 05),而与年龄、病理类型无关(P>0. 05);CTNNB1高表达者生存时间与5年内存活率明显低于CTNNB1低表达者(P<0. 05);miR-34高表达者生存时间与5年内存活率明显高于miR-34低表达者(P<0. 05);通过COX回归分析显示,CTNNB1、miR-34及淋巴结转移和FIGO分期是影响卵巢癌患者预后的危险因素。结论卵巢癌组织中CTNNB1呈高表达,miR-34呈低表达,且二者均与临床病理特征及预后密切相关,推测二者均可作为监测卵巢癌发生发展及评估预后的重要指标。 展开更多
关键词 卵巢癌 ctnnb1 miR-34 病理特征 预后
原文传递
上一页 1 2 3 下一页 到第
使用帮助 返回顶部